The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Cerecin: A research and clinical trials success story
Global pharmaceutical company Cerecin, which develops therapeutics for neurological disorders, is undertaking clinical trials and expanding its research capabilities in Melbourne, Australia. Charles Stacey, Cerecin’s President and CEO, explains why it has chosen Australia to expand its global footprint. Benefits include its diverse population mix, R&D incentives and human capital.
Do business with Australia
Invest in the Australian market - buy from Australian suppliers.
